Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

Cartesian Therapeutics (RNAC) Interest Coverage Ratio (2016 - 2023)

Cartesian Therapeutics (RNAC) has disclosed Interest Coverage Ratio for 9 consecutive years, with 10.26 as the latest value for Q3 2023.

  • Quarterly Interest Coverage Ratio fell 414.76% to 10.26 in Q3 2023 from the year-ago period, while the trailing twelve-month figure was 38.48 through Jun 2024, down 158.84% year-over-year, with the annual reading at 30.5 for FY2023, 735.96% down from the prior year.
  • Interest Coverage Ratio for Q3 2023 was 10.26 at Cartesian Therapeutics, up from 24.78 in the prior quarter.
  • The five-year high for Interest Coverage Ratio was 19.38 in Q2 2022, with the low at 79.84 in Q2 2020.
  • Average Interest Coverage Ratio over 5 years is 19.9, with a median of 11.08 recorded in 2020.
  • The sharpest move saw Interest Coverage Ratio surged 2949.22% in 2022, then tumbled 414.76% in 2023.
  • Over 5 years, Interest Coverage Ratio stood at 37.52 in 2019, then soared by 70.48% to 11.08 in 2020, then surged by 151.78% to 5.74 in 2021, then crashed by 283.55% to 10.53 in 2022, then grew by 2.51% to 10.26 in 2023.
  • According to Business Quant data, Interest Coverage Ratio over the past three periods came in at 10.26, 24.78, and 22.75 for Q3 2023, Q2 2023, and Q1 2023 respectively.